Important Clinical Research Notice

Disclaimer: PCH MedSpa does not sell, compound, or commercially dispense Retatrutide. The content on this page is strictly for educational and informational purposes. PCH MedSpa does not host clinical trials or provide pre-screening evaluations for this medication. Please consult with our qualified healthcare team to discuss the FDA-approved weight management therapies currently available at our practice.

Retatrutide Weight Loss Treatment in Newport Beach: Next-Generation Medical Weight Loss

  • Homepage
  • >
  • Retatrutide Weight Loss Treatment in Newport Beach

PCH MedSpa in Corona Del Mar is proud to offer Retatrutide, the most advanced medical weight loss treatment available. This revolutionary triple hormone therapy has demonstrated up to 24% total body weight loss in clinical trials—surpassing results from Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound).

Serving Newport Beach, Orange County, and surrounding communities, Dr. Kaveh Karandish combines cutting-edge pharmaceutical therapies with personalized medical supervision to help patients achieve life-changing results.

Retatrutide Weight Loss Treatment in Newport Beach

Ready to learn more? Call (949) 242-9166 or Book Your Consultation

What is Retatrutide?

24% Average Weight Loss Total Body Weight in 48 Weeks
58% Lost ≥20% Body Weight At Highest Dose
91% Lost ≥5% Body Weight Clinical Trial Participants
3X Triple Action GLP-1 + GIP + Glucagon

Retatrutide (LY3437943) is the world’s first triple hormone receptor agonist for weight loss. Unlike earlier medications that target one or two pathways, Retatrutide simultaneously activates three metabolic receptors:

  1. GLP-1 Receptor → Controls appetite and reduces food intake
  2. GIP Receptor → Enhances metabolism and insulin sensitivity
  3. Glucagon Receptor → Increases fat burning and energy expenditure

This triple-action mechanism creates synergistic effects that deliver superior weight loss compared to single or dual-action medications.

Weight Loss Timeline

Expected Weight Loss Timeline

Based on a 250 lb starting weight with 24% total loss goal

Month 1
5-10 lbs
Appetite reduction, initial water weight
Months 2-3
10-20 lbs
Consistent steady weight loss
Months 4-6
20-35 lbs
Accelerated fat loss phase
Months 7-12
35-60 lbs
Approaching goal weight

* Individual results vary based on starting weight, adherence, and metabolic factors. Target 1-2 lbs per week for sustainable results.

How Retatrutide Works

Clinical Trial Results

48-Week Phase 2 Study:

  • Average weight loss: 24.2% of total body weight (highest dose)
  • 58% of participants lost ≥20% of body weight
  • 91% of participants lost ≥5% of body weight
  • Significant improvements in blood sugar, blood pressure, and cholesterol

For context: A 250 lb person losing 24% would lose approximately 60 pounds.

Triple Action Mechanism

How Retatrutide's Triple Action Works

Triple-Action Mechanism

🍽️
GLP-1 Activation
Appetite Control
Reduces hunger and cravings, slows gastric emptying for prolonged fullness, improves blood sugar control, and eliminates constant food thoughts.
GIP Activation
Enhanced Metabolism
Improves insulin sensitivity, enhances fat metabolism, supports healthy cholesterol levels, and complements GLP-1 action synergistically.
🔥
Glucagon Activation
The Game-Changer)
Increases resting energy expenditure, promotes active fat burning, preserves lean muscle mass, and boosts overall metabolic rate.

This comprehensive approach addresses weight loss from every angle, which is why Retatrutide delivers unprecedented results.

Retatrutide vs. Other Weight Loss Medications

How Does Retatrutide Compare?

Comparison Table
FeatureRetatrutideTirzepatideSemaglutide
Mechanism of ActionTriple (GLP-1/GIP/Glucagon)Dual (GLP-1/GIP)Single (GLP-1)
Average Weight Loss24% of body weight20% of body weight15% of body weight
FDA Approval StatusPhase 3 Clinical TrialsApproved (2023)Approved (2021)
Injection FrequencyWeeklyWeeklyWeekly
Best For Weight Goal50+ pounds30-75 pounds20-50 pounds
Metabolic BenefitsExcellentVery GoodGood
Long-term Safety DataLimited (New)Moderate (2+ years)Extensive (5+ years)
Approx. Monthly Cost$1,200-$1,500$1,000-$1,350$900-$1,200
Insurance CoverageUnlikely (Currently)SometimesSometimes
Ideal CandidateMaximum results neededBalanced efficacy & safetyEstablished option

Retatrutide shows 15-60% greater weight loss compared to other GLP-1 medications.

Retatrutide:

  • Mechanism: Triple (GLP-1/GIP/Glucagon)
  • Avg Weight Loss: 24%
  • FDA Status: Clinical trials

Tirzepatide:

  • Mechanism: Dual (GLP-1/GIP)
  • Avg Weight Loss: 20%
  • FDA Status: Approved 2023

Semaglutide:

  • Mechanism: Single (GLP-1)
  • Avg Weight Loss: 15%
  • FDA Status: Approved 2021

When to Choose Retatrutide

Retatrutide is ideal if you:

  • Need to lose 50+ pounds
  • Plateaued on Semaglutide or Tirzepatide
  • Want maximum possible results
  • Have metabolic syndrome or type 2 diabetes
  • You are seeking cutting-edge therapy

Alternative options may be better if you:

  • Need to lose <30 pounds
  • Prefer FDA-approved medications
  • Want established long-term safety data
  • Insurance coverage is a priority

During your consultation, Dr. Karandish will help you determine which option best suits your goals.

Your Retatrutide Treatment Journey at PCH MedSpa

STEP 1 - EVALUATION

Comprehensive Consultation

Review medical history, goals, and conduct a physical exam to determine if Retatrutide is right for you.

1
Consultation
STEP 2 - ASSESSMENT

Medical Evaluation

Thorough medical testing including metabolic panel, lipid panel, HbA1c, thyroid, and liver/kidney function tests.

2
Medical Eval
STEP 3 - CUSTOMIZATION

Personalized Treatment Plan

A customized plan tailored to your needs, including medication protocol, dosing schedule, and nutritional guidance.

3
Custom Plan
STEP 4 - INITIATION

Treatment Begins

Start weekly injections with a gradual escalation protocol, beginning with 2 mg weekly.

4
Initiation
STEP 5 - MONITORING

Ongoing Medical Supervision

Continuous support with weekly check-ins during month one and bi-weekly/monthly follow-ups thereafter.

5
Supervision
STEP 6 - SUCCESS

Achieve Your Goals

Reach your target weight and transition to a maintenance strategy designed for long-term success.

6
Success

What to Expect:

  • Complete medical history review
  • Physical examination and body composition analysis
  • Discussion of weight loss goals
  • Evaluation of eligibility
  • Personalized treatment plan

Duration: 45-60 minutes
Cost: Call (949) 242-9166 for current pricing

Required Testing:

  • Comprehensive metabolic panel
  • Lipid panel and HbA1c
  • Thyroid function tests
  • Liver and kidney function
  • Pregnancy test (if applicable)

Dosing Schedule:

  • Weeks 1-4: 2 mg weekly (starting dose)
  • Weeks 5-8: 4 mg weekly
  • Weeks 9-12: 8 mg weekly
  • Week 13+: 12 mg weekly (maintenance)

Administration:

  • Weekly subcutaneous injection (self-administered or in-office)
  • Pre-filled pens for convenience
  • Injection training provided

Regular Monitoring:

  • Weekly check-ins (Month 1)
  • Bi-weekly appointments (Months 2-3)
  • Monthly follow-ups (Month 4+)
  • Lab work every 3-6 months

Comprehensive Care:

  • Nutritional counseling
  • Exercise guidance
  • Side effect management
  • Direct access to Dr. Karandish

Are You a Candidate for Retatrutide?

Ideal Candidates
Not Recommended For
BMI ≥30 or BMI ≥27 with weight-related health conditions
Personal or family history of medullary thyroid cancer
Need to lose 50+ pounds
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Plateaued on other GLP-1 medications (Semaglutide, Tirzepatide)
Pregnancy, planning pregnancy, or breastfeeding
Type 2 diabetes or metabolic syndrome
Active eating disorders (anorexia, bulimia)
Previous unsuccessful diet and exercise attempts
History of severe pancreatitis
Committed to lifestyle changes and follow-up care
Unable to commit to regular follow-up appointments
Seeking maximum possible weight loss results
Severe kidney or liver disease
Ready for cutting-edge, physician-supervised therapy
Under 18 years of age

Who Is a Candidate for Retatrutide?

You May Be an Excellent Candidate If:

✅ BMI ≥30 (or ≥27 with weight-related conditions)
✅ Need to lose significant weight (30+ pounds)
✅ Previous diet and exercise attempts unsuccessful
✅ Plateaued on other weight loss medications
✅ Committed to lifestyle changes
✅ Able to attend regular follow-ups

Contraindications:

❌ Personal/family history of medullary thyroid cancer
❌ Multiple Endocrine Neoplasia syndrome type 2
❌ Pregnancy or breastfeeding
❌ History of severe pancreatitis
❌ Active eating disorders

Not sure if you qualify? Schedule a consultation: (949) 242-9166

Safety and Side Effects

Common Side Effects (Usually Temporary)

Gastrointestinal (Most Common):

  • Nausea (60-70% of patients, typically mild)
  • Diarrhea or constipation
  • Abdominal discomfort
  • Decreased appetite (therapeutic)

Other:

  • Mild fatigue (first month)
  • Headache
  • Injection site reactions

Management: Side effects typically improve within 1-2 weeks. Dr. Karandish provides anti-nausea medications and dietary strategies to minimize symptoms.

Serious Side Effects (Rare)

Seek immediate medical attention if you experience:

  • Severe abdominal pain
  • Signs of pancreatitis
  • Severe allergic reaction
  • Persistent vomiting/dehydration

Black Box Warning: Like all GLP-1 medications, Retatrutide carries a warning about thyroid C-cell tumors based on animal studies. Dr. Karandish screens all patients for risk factors.

Cost and Insurance

Investment in Your Health

Approximate Costs:

  • Monthly medication: $500-$750, depending on dosage
  • Initial consultation: $100-$200
  • Follow-up visits: Included or $75-$150
  • Lab work: $100-$150 (initial), $50-$70 (follow-up)

First-Year Total: $6,750-$11,700 (including all medical supervision)

Insurance Coverage

  • Currently unlikely (not yet FDA-approved)
  • HSA/FSA funds can typically be used
  • May be covered for diabetes (off-label, requires authorization)
  • PCH MedSpa provides documentation for insurance submission

Financing Options

  • Monthly payment plans
  • 0% interest financing (with approved credit)
  • Package discounts (3, 6, 12-month programs)
  • CareCredit medical financing

Call (949) 242-9166 to discuss payment options

Frequently Asked Questions

How much weight will I lose on Retatrutide?

Most patients notice appetite suppression within the first week. Visible weight loss typically begins in weeks 2-4, with more significant changes by months 2-3. Average timeline: 5-10 lbs (month 1), 20-35 lbs (months 4-6), 35-60 lbs (months 7-12).

Clinical trial participants lost an average of 24.2% of body weight over 48 weeks. Individual results vary based on starting weight, adherence, and metabolism. Dr. Karandish will discuss realistic expectations during your consultation.

Ozempic and Wegovy contain Semaglutide, which activates only the GLP-1 receptor. Retatrutide activates three receptors (GLP-1, GIP, and glucagon), delivering approximately 60% greater weight loss than Semaglutide.

Retatrutide is currently in Phase 3 clinical trials and not yet FDA-approved. Dr. Karandish prescribes it off-label based on exceptional Phase 2 safety and efficacy data.

While Retatrutide significantly reduces appetite, optimal results require healthy nutrition and regular physical activity. Think of it as a powerful tool that makes healthy habits easier to maintain, not a substitute for them.

Yes, but we don’t recommend stopping abruptly. Dr. Karandish helps you switch to a maintenance plan. This may include a lower dose, a different medication, or just lifestyle changes. This plan aims to keep your results for the long term.

Many patients successfully transition to Retatrutide after plateauing on other GLP-1 medications. The switch involves discontinuing your current medication, a short wash-out period, and starting Retatrutide at the appropriate dose.

Some loose skin is possible with significant weight loss (50+ lbs), but severity depends on age, genetics, rate of weight loss, and exercise. PCH MedSpa offers body contouring and skin tightening treatments to address concerns after weight loss.

Have more questions? Call (949) 242-9166 or Book Your Consultation

Why Choose PCH MedSpa for Retatrutide in Newport Beach

Dr. Kaveh Karandish: Expertise You Can Trust

  • Board-certified physician with specialized training in medical weight loss
  • Founder of the Endolift Training Academy
  • Extensive experience with GLP-1 and metabolic therapies
  • Holistic approach combining medication with lifestyle guidance

Comprehensive Medical Supervision

✅ Personalized treatment plans
✅ Regular monitoring and lab work
✅ Proactive side effect management
✅ Direct access to Dr. Karandish
✅ Nutrition and exercise counseling

Convenient Corona Del Mar Location

2801 E. Coast Hwy, Corona Del Mar, CA 92625

Serving Newport Beach, Laguna Beach, Irvine, Costa Mesa, and all of Orange County.

State-of-the-Art Facility

  • Modern, comfortable treatment rooms
  • Luxurious spa-like atmosphere
  • Comprehensive aesthetic and wellness services
  • One-stop solution for all your health goals

Transparent Pricing and Flexible Financing

  • Clear, upfront costs
  • Package discounts available
  • Multiple payment options
  • HSA/FSA accepted

Take the First Step Toward Transformative Weight Loss

Imagine yourself six months from now: 40-60 pounds lighter, with more energy, improved health markers, and greater confidence. That future is within reach with Retatrutide and expert guidance from Dr. Karandish.

Schedule Your Consultation Today

Three Easy Ways to Get Started:

  1. Call: (949) 242-9166
  2. Book Online: Schedule Consultation
  3. Email: info@pchmedspa.com

📍 PCH MedSpa
2801 E. Coast Hwy
Corona Del Mar, CA 92625

Hours:
Monday-Friday: 9:00 AM – 6:00 PM
Saturday: By Appointment

About the Author
Dr. Kaveh Karandish, MD — PCH MedSpa
Written & Medically Reviewed by
Dr. Kaveh Karandish
MD  ·  Internal Medicine  ·  Aesthetic & Regenerative Medicine
Endolift Expert Regenerative Medicine Aesthetic Medicine Preventive Medicine Rheumatology
Credentials
Education: MD — Central Health America University (2005)
Board Certified: ABIM · 20+ Years of Experience
Academic: Asst. Professor, Univ. of Miami
Faculty: Aesthetic Show Speaker & Faculty
KOL Affiliations
EndoLift International KOL ToskaniMed KOL Viola Threads KOL Alma Threads KOL